CNBTD
GILD icon

Citizens National Bank Trust Department’s Gilead Sciences GILD Stock Holding History

Citizens National Bank Trust Department’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-128
Closed -$8K – 319
2022
Q3 		$8K Hold
128
– – ﹤0.01% 283
2022
Q2 		$8K Hold
128
– – ﹤0.01% 289
2022
Q1 		$8K Hold
128
– – ﹤0.01% 268
2021
Q4 		$9K Buy
+128
New +$8.82K ﹤0.01% 263

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citizens National Bank Trust Department's GILD Position: Q4 2022 in Review

Citizens National Bank Trust Department sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 128 shares — an estimated $8K sold.

Citizens National Bank Trust Department first reported a position in GILD in Q4 2021 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Citizens National Bank Trust Department reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Citizens National Bank Trust Department sold 128 Gilead Sciences shares in Q4 2022, an estimated $8K.
  • Citizens National Bank Trust Department first reported a position in Gilead Sciences in Q4 2021 and held it in 4 quarters.
  • Citizens National Bank Trust Department's Gilead Sciences position peaked at $9K in Q4 2021.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Citizens National Bank Trust Department's 13F filing for Q4 2022, filed 9 Feb 2023.